Why is Antimicrobial Susceptibility Testing a Key Player in Stewardship Programs?
JUN 13, 2017 | CONTAGION® EDITORIAL STAFF
James S. Lewis, PharmD, FIDSA, Co-Director of Antibiotic Stewardship, Oregon Health and Science University, explains why antimicrobial susceptibility testing is so important when it comes to stewardship programs.
Interview Transcript (slightly modified for readability)
“Antimicrobial susceptibility testing is really key to any antibacterial stewardship program because without those results, one of the key components of stewardship, which is de-escalation, is largely impossible.
The other tenant of antibiotic stewardship that really is absolutely critical with regards to antimicrobial susceptibility testing, is that you have to make sure that patients have the appropriate therapy in a timely manner. Without those susceptibility results, you’re in basically a limbo, where you’re never sure whether or not the therapy is appropriate, and so, really susceptibility testing drives the vast majority of what it is that we do in a day-in, day-out basis with regards to stewardship.” DISCLOSURES: Jim Lewis is a consultant for Accelerate Diagnostics, The Medicines Company, Merck and Achaogen.
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
The new test can differentiate between Lyme disease and 7 other tick-borne diseases.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512